HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin E antibody against environmental allergens in subjects with trimellitic anhydride-induced asthma.

Abstract
The purpose of this study was to assess the relationship between atopy and the development of occupational asthma as a consequence of exposure to trimellitic anhydride (TMA). A case-control study was performed, which comprised 16 employees identified as having TMA-induced asthma and 44 similarly exposed controls. Specific immunoglobulin E measurements in response to cat, dust mite, ryegrass, and ragweed antigens were performed. Fifty-six percent of cases and 29% of controls were found to be atopic (P = 0.098). We demonstrated that there was a trend toward employees with TMA asthma being more atopic than those without TMA asthma. Atopy as an assessment of risk for the development of TMA asthma is unlikely to be useful, although further investigation may be warranted.
AuthorsR Sikora, K E Harris, B Kenamore, L C Grammer
JournalJournal of occupational and environmental medicine (J Occup Environ Med) Vol. 41 Issue 3 Pg. 190-4 (Mar 1999) ISSN: 1076-2752 [Print] United States
PMID10091142 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants, Occupational
  • Allergens
  • Phthalic Anhydrides
  • Immunoglobulin E
  • trimellitic anhydride
Topics
  • Adult
  • Air Pollutants, Occupational (adverse effects, immunology)
  • Allergens (adverse effects, immunology)
  • Asthma (chemically induced, immunology)
  • Case-Control Studies
  • Chi-Square Distribution
  • Female
  • Humans
  • Immunoglobulin E (blood)
  • Male
  • Occupational Diseases (chemically induced, immunology)
  • Odds Ratio
  • Phthalic Anhydrides (adverse effects, immunology)
  • Risk Factors
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: